IDO1 and Zika virus infectious disease: Finally, as demonstrated during 1-MT treatment, intracranial ZIKV infection also led to increased production of inflammatory mediators, such as CCL5 (Figure 5E) and CXCL1 (Figure 5F) in both WT and IDO-1-/- ZIKV mice.